Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin

Yu, M; Shankar, RR; Zhang, RY; Zhang, Y; Lin, JX; O'Neill, EA; Chen, GJ; Liu, S; Tu, YM; Engel, SS

Shankar, RR (reprint author), Merck Res Labs, POB 2000 RY34-A260, Rahway, NJ 07065 USA.

DIABETES OBESITY & METABOLISM, 2019; 21 (2): 408

Abstract

To improve understanding of the safety and efficacy of adding sitagliptin to treatment of patients with type 2 diabetes taking premixed insulin, data ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索